INTEGRATION OF AAV2 GENOME TO MUSCLE-SPECIFIC DNA REGION
AAV2 基因组与肌肉特异性 DNA 区域的整合
基本信息
- 批准号:6881839
- 负责人:
- 金额:$ 12.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-02-01 至 2006-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Copied from Applicant Abstract): Adeno-associated virus type 2
(AAV) is unique in the ability to integrate its genome site-specifically into
the human genome in a region on the q-arm of human chromosome 19 designated
AAVSI. Most intriguingly, only one viral gene product, the Rep protein, is
required to mediate targeted integration, presumably in concert with host cell
factors. This characteristic of AAV has made possible a novel concept for
therapeutic gene delivery: the targeted integration of a transgene into a
defined locus within the human genome. Prerequisite for the usefulness of this
approach is the characterization of the human target region as well as of the
rearrangements resulting from Rep-mediated AAV DNA integration.
We have found that the gene encoding the slow skeletal muscle troponin T
(TNNTI) is located Ca. 14 kb telomeric to AA VS1 Furthermore, we show that
TNNTI can be disrupted as a result of site-specific AAV DNA integration. These
data allow us to answer the following questions: 1. Is transcriptional activity
in the region of AAVSI required for and/or does it enhance the AAV integration
efficiency? 2. Does transcription from this region, i.e. from the TNNTJ gene,
affect expression of a transgene inserted into AA VSI. 3. Does targeted
insertion of AAV or rAAV DNA into AAVS1 potentially lead to phenotypic changes
in the infected cell due to disruption of the expression of a proximal gene
(now shown to be TNNT1).
To date, skeletal muscle has been one of the most successful tissues for AAV
mediated gene transfer. We propose to answer these questions in order to
establish if skeletal muscle might serve as a suitable tissue for site-specific
gene delivery into AAVS1.
描述(复制自申请人摘要):腺相关病毒2型
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RALPH MICHAEL LINDEN其他文献
RALPH MICHAEL LINDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RALPH MICHAEL LINDEN', 18)}}的其他基金
AAV-mediated targeted DNA integration in mouse ES cells
AAV 介导的小鼠 ES 细胞中的靶向 DNA 整合
- 批准号:
7491818 - 财政年份:2005
- 资助金额:
$ 12.71万 - 项目类别:
AAV-mediated targeted DNA integration in mouse ES cells
AAV 介导的小鼠 ES 细胞中的靶向 DNA 整合
- 批准号:
7123798 - 财政年份:2005
- 资助金额:
$ 12.71万 - 项目类别:
AAV-mediated targeted DNA integration in mouse ES cells
AAV 介导的小鼠 ES 细胞中的靶向 DNA 整合
- 批准号:
7032149 - 财政年份:2005
- 资助金额:
$ 12.71万 - 项目类别:
GROWTH, DIFFERENTIATION AND GENETIC ALTERATION OF HUMAN ES CELLS
人类 ES 细胞的生长、分化和遗传改变
- 批准号:
7092811 - 财政年份:2005
- 资助金额:
$ 12.71万 - 项目类别:
AAV-mediated targeted DNA integration in mouse ES cells
AAV 介导的小鼠 ES 细胞中的靶向 DNA 整合
- 批准号:
7278592 - 财政年份:2005
- 资助金额:
$ 12.71万 - 项目类别:
INTEGRATION OF AAV2 GENOME TO MUSCLE-SPECIFIC DNA REGION
AAV2 基因组与肌肉特异性 DNA 区域的整合
- 批准号:
6498857 - 财政年份:2001
- 资助金额:
$ 12.71万 - 项目类别:














{{item.name}}会员




